Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Licence to publish

We do not require authors to transfer copyright. Instead, authors are requested to sign and return a ‘licence to publish’ once an article has been accepted for publication (version of license will depend on open access option — see Author options post-acceptance below). Authors can select the most suitable form of open access.

Author options post-acceptance

Open Access - Green

Authors of review articles are encouraged to submit the author’s version of the accepted paper (the unedited manuscript) to their funding body’s archive for public release six months after publication. In addition, authors are encouraged to archive this version of the manuscript in their institution’s repositories and on their personal websites six months after publication.

Open Access - Gold

Authors of peer-reviewed articles can also opt to pay an article processing charge (in lieu of the standard publication charges) for their accepted articles to be open access online and freely accessible immediately upon publication. By paying this charge, authors are also permitted to post the final, published version of their article on a website, institutional repository or other free public server immediately on publication.

Open access articles can be published either under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International License, a Creative Commons Attribution-Noncommercial-Share Alike 4.0 International License, or a Creative Commons Attribution 4.0 International License at the free choice of the authors.

Pharmaceutical Journal Publications’ publishing policies ensure that authors can fully comply with the public access requirements of the major funding bodies worldwide (http://www.sherpa.ac.uk/romeo/journals.php?id=416&fIDnum=&mode=simple&letter=ALL). However, it is the author’s responsibility to take the necessary actions to achieve compliance. This may include self-archiving or choosing open access publication under the appropriate licence type choice.

 

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £250.00Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £130.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Site powered by Webvision